昊海生物科技(06826.HK)董事長建議以最多2億元人幣回購A股
昊海生物科技(06826.HK)公布,董事長侯永泰建議公司以集中競價交易方式回購A股,回購股份將於未來合適時機,用於員工持股計劃或股權激勵計劃。
侯永泰建議公司以自有資金1億至2億元人民幣進行回購,每股A股作價不超過130元人民幣,涉及股份數目76.9萬至153.8萬股,相當於公司總股本約0.45%至0.9%。若回購股份在三年內未使用,將予以注銷。
侯永泰並無計劃在回購期間減持,並承諾對回購議案投贊成票。公司將盡快研究回購方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.